Granulocyte-macrophage colony-stimulating factor dependent monocyte-mediated cytotoxicity post-autologous bone marrow transplantation

Leukemia Research

Volumn 20, Issue 8, 1996, Pages 637-643

  Nagler, Arnon ^a   Shur, Irena ^b   Barak, Vivian ^a   Fabian, Ina ^b  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CD16 ANTIGEN; CYTOKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANTIGEN EXPRESSION; ANTINEOPLASTIC ACTIVITY; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BREAST CANCER; CELL MEDIATED CYTOTOXICITY; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HODGKIN DISEASE; HUMAN; MALE; MONOCYTE; NEUROBLASTOMA; NONHODGKIN LYMPHOMA; PRESCHOOL CHILD; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT OUTCOME;

EID: 0030221693     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/0145-2126(96)00025-2     Document Type: Article

References (45)

1. 1. Freedman A. S., Takvorian T., Neuberg D., Mauch P., Rabinowe S. N., Anderson K. C., Soiffer R. J., Spector N., Grossbard M., Robertson M. J., Blake K., Coral F., Canellos G. P., Ritz J. & Nadler L.M. (1993) Autologous bone marrow transplantation in poor-prognosis intermediate-grade and high-grade B-cell non-Hodgkin's lymphoma in first remission: a pilot study. J. Clin. Oncol. 11, 931.
2. 2. Phillips G. L., Fay J. W., Herzig R. H., Lazarus H. M., Wolff S. T., Lin H. S., Shina D. C., Glassgow G. P., Griffith R. C., Lamb C. W. & Herzig G. P. (1990) The treatment of progressive non-Hodgkin's lymphoma with intensive-chemoradiotherapy and autologous marrow transplantation. Blood 75, 831.
3. 3. Chopra R., McMillan A. K., Linch D. C., Yuklea S., Taghipour G., Pearce R., Patterson K. G. & Goldstone A. H. (1993) The place of high-dose BEAM therapy and autologous bone marrow transplantation in poor-risk-Hodgkin's disease. A single-center eight-year study of 155 patients. Blood 81, 1137.
4. 4. Bierman P. J., Vose J. M. & Armitage J. O. (1994) Autologous transplantation for Hodgkin's disease: Coming of age? Blood 83, 1161.
5. 5. Johnson F. L. & Goldman S. (1993) Autologous bone marrow transplantation: Role of autotransplantation in neuroblastoma. Hematology/Oncology Clinics of North America 7, 647.
6. 6. Kapelushnik J., Nagler A., Or R., Naparstek E., Cividalli G., Aker M., Mehta J., Mumcuoglu M. & Slavin S. (1993) Autologous bone marrow transplantation for stage IV neuroblastoma: the role of soybean agglutinin purging. Transplant. Proc. 25, 2375.
7. 7. Ferguson J. E., Dodwell D. J., Seymour A. M., Richards M. A. & Howell A. (1993) High dose, dose-intensive chemotherapy with doxorubicin and cyclophosphamide for the treatment of advanced breast cancer. Br. J. Cancer 67, 825.
8. 8. Slavin S. & Nagler A. (1991) New developments in bone marrow transplantation. Curr. Opinion Oncol. 3, 254.
9. 9. Mehta J. (1993) Graft-versus-leukemia reactions in clinical bone marrow transplantation. Leukemia Lymphoma 10, 427.
10. 10. Rees R. C. & Parry H. (1992) Macrophages in tumor immunity. In The Macrophage (Lewis C. E. and McGee J. O'D., Eds). Oxford University Press, Oxford.
11. 11. Mantovani A., Bottazzi B., Colotta F., Sozzani S. & Ruco L. (1992) The origin and function of tumor-associated macrophages. Immunol. Today 13, 265.
12. 12. Grabstein K. H., Urdal D. L., Tushinski R. J., Mochizuki D. Y., Price V. L., Cantrell M. A., Gillis S. & Conlon P. J. (1986) Induction of macrophage tumoricidal activity by granulocyte-macrophage colony stimulating factor. Science 232, 506.
13. 13. Munn D. H., Garnick M. B. & Cheung N. K. V. (1990) Effects of parenteral recombinant human macrophage colony-stimulating factor on monocyte number, phenotype, and antitumor cytotoxicity in nonhuman primates. Blood 75, 2042.
14. 14. Higuchi M., Higashi N., Taki H. & Osawa T. (1990) Cytolytic mechanisms of activated macrophages, tumor necrosis factor and L-arginine-dependent mechanisms act synergistically as the major cytolytic mechanisms of activated macrophages. J. Immunol. 144, 1425.
15. 15. Munn D. H. & Cheung N. K. V. (1989) Antibody-dependent antitumor cytotoxicity by human monocytes cultured with recombinant macrophage colony-stimulating factor. J. exp. Med. 170, 511.
16. 16. Johnson W. J., Steplewski Z., Matthews T. J., Hamilton T. A., Kroprowski H. & Adams D. O. (1986) Cytolytic interactions between murine macrophages, tumor cells, and monoclonal antibodies: characterization of lytic conditions and requirements for effector activation. J. Immunol. 136, 4704.
17. 17. Fidler I. J. & Ichinose Y. (1989) Mechanisms of macrophage-mediated tumor cell lysis: role for the monokines tumor necrosis factor and interleukin-1. Prog. Clin. Biol. Res. 288, 169.
18. 18. Parry H. J. & Rees R. C. (1992) Differential effects of human blood monocytes on the growth of human tumor cell lines in vitro. Cancer Immunol. Immunother. 34, 355.
19. 19. Zyad A., Branellec D., Mahe Y., Tursz T. & Chouaib S. (1992) The development of human tumor-cell resistance to TNF-alpha does not confer resistance to cytokine-induced cellular cytotoxic mechanisms. Int. J. Cancer 52, 953.
20. 20. Tang R., Beuvon F., Ojeda M., Mosseri V., Pouillart P. & School S. (1992) M-CSF (monocyte colony stimulating factor) and M-CSF receptor expression by breast tumor cells: M-CSF mediated recruitment of tumor infiltrating monocytes? J. Cell Biochem. 50, 350.
21. 21. Gorin N. C., Coiffier B., Hayat M., Philip T., Fouillard L., Kuentz M., Herve P., Colombat P., Boivin P., Slavin S., Lemarie J. C. & Eugene-Jolchine I. (1992) Recombinant human granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation with unpurged and purged marrow in non Hodgkin's lymphoma: a double blind placebo controlled trial. Blood 80, 1149.
22. 22. Link H., Boogaerts M., Carella A. M., Link H., Boogaerts M., Ferrant A., Gadner H., Gorin N. C., Harabacz I., Harrousseau F., Herve P., Kolb H. J., Krieger O., Labar B., Luft S., Mandelli F., Maraninchi D., Nicolay U., Niederwieser D., Oster W., Reiffers J., Rizzoli V., Schulz G., Siegert W., Slavin S., Vernant J. P. & de Witte T. (1994) Recombinant human granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for acute lymphoblastic leukemia or malignant lymphoma: an international, double-blind, placebo-controlled trial. Blood 84, 3327.
23. 23. Gadish M., Kletter Y., Flidel O., Nagler A., Slavin S. & Fabian I. (1991) Effects of recombinant human granulocyte and granulocyte-macrophage colony-stimulating factor on neutrophil function following autologous bone marrow transplantation. Leukemia Res. 15, 1175.
24. 24. Fabian I., Shapira E., Gadish M., Kletter Y., Nagler A., Flidel O. & Slavin S. (1992) Effects of human interleukin 3, macrophage and granulocyte-macrophage colony-stimulating factor on monocyte function following autologous bone marrow transplantation. Leukemia Res. 16, 703.
25. 25. Brochu S., Perreault C. & Belanger R. (1989) Evaluation of Fc-dependent granulocyte-macrophage function in bone marrow transplant recipients. Exp. Haematol. 17, 948.
26. 26. De Witte T., Gratwohl A., Van Der Lely N., Bacigalupo A., Stern A. C., Speck B., Schattenberg A., Nissen C., Gluckman E. & Fibbe W. E. (1992) Recombinant human granulocyte-macrophage colony-stimulating factor accelerates neutrophil and monocyte recovery after allogeneic T-cell-depleted bone marrow transplantation. Blood 79, 1359.
27. 27. Yuo A., Kitagawa S., Motoyoshi K., Azuma E., Saito M. & Takaku F. (1992) Rapid priming of human monocytes by human hematopoietic growth factors: granulocyte-macrophage colony-stimulating factor (CSF), macrophage-CSF, and interleukin-3 selectively enhance superoxide release triggered by receptor-mediated agonists. Blood 79, 1553.
28. 28. Wing E. J., Mitchell Magee D., Whiteside T. L., Kaplan S. S. & Shadduck R. K. (1989) Recombinant human granulocyte-macrophage colony-stimulating factor enhances monocyte cytotoxicity and secretion of tumor necrosis factor α and interferon in cancer patients. Blood 73, 643.
29. 29. Horiguchi J., Warren M. K. & Kufe D. (1987) Expression of the macrophage-specific colony-stimulating factor in human monocytes treated with granulocyte-macrophage colony-simulating factor. Blood 69, 1259.
30. 30. Smith P. D., Lamerson C. L., Wong H. L., Wahl L. M. & Wahl S. M. (1990) Granulocyte-macrophage colony-stimulating factor stimulates human monocyte accessory cell function. J. Immunol. 144, 3829.
31. 31. Reid C. D., Stackpoole A., Meager A. & Tikerpae J. (1992) Interactions of tumor necrosis factor with granulocyte-macrophage colony-stimulating factor and other cytokines in the regulation of dendritic cell growth in vitro from early bipotent CD34+ progenitors in human bone marrow. J. Immunol. 149, 2681.
32. 32. De Witte T., Vreugdenhil G. & Schattenberg A. (1993) Prolonged administration of recombinant granulocyte-macrophage colony-stimulating factor (GM-CSF) after T-cell-depleted allogeneic bone marrow transplantation. Transplant. Proc. 25, 57.
33. 33. Gulati S. C. & Bennett C. L. (1992) Granulocyte-macrophage colony-stimulating factor (GM-CSF) as adjunct therapy in relapsed Hodgkin disease. Ann. Int. Med. 116, 177.
34. 34. Fabian I., Kravtsov V., Elias A., Gurevitch O., Ackerstein A., Slavin S. & Nagler A. (1994) Eosinophils activation in post autologous bone marrow transplanted patients treated with subcutaneous interleukin-2 and interferon-α2A immunotherapy. Leukemia 8, 1379.
35. 35. Barak V., Levi-Schafer F., Kalickman I. & Nagler A. (1995) Cytokine dysregulation in chronic graft versus host disease (cGVHD). Leukemia Lymphoma 17, 169.
36. 36. Engelhard D., Nagler A., Singer R. & Barak V. (1993) Soluble interleukin-2 receptor levels in cytomegalovirus disease and graft versus host disease after T-lymphocyte depleted bone marrow transplantation for hematological neoplasias. Leukemia Lymphoma 12, 273.
37. 37. Lanier L. L, Yu G. & Phillips J. H. (1991) Analysis of Fc gamma RIII (CD16) membrane expression and association with CD3 zeta and Fc epsilon RI-gamma by site-directed mutation. J. Immunol. 146, 1571.
38. 38. Suzu S., Yokota H., Yamada M., Yanai N., Saito M., Kawashima T., Saito M., Takaku F. & Motoyoshi K. (1989) Enhancing effect of human monocytic colony-stimulating factor on monocyte tumoricidal activity. Cancer Res. 49, 5913.
39. 39. Sampson-Johannes A. & Carlino J. A. (1988) Enhancement of human monocyte tumoricidal activity by recombinant M-SCF. J. Immunol. 141, 3680.
40. 40. Alderson M. R., Tough T. W., Ziegler S. F. & Armitage R. J. (1992) Regulation of human monocyte cell-surface and soluble CD23 (FCεRII) by granulocyte-macrophage colony-stimulating factor and IL-3. J. Immunol. 149, 1252.
41. 41. Loosdrecht A. A. van de, Beelen R. H. J., Ossenkoppele G. J., Broekhoven M. G. & Langehuijsen M. M. A. C. (1993) Cellular and cytokine dependent monocyte-mediated leukemic cell death: modulation by interferon-γ and tumor necrosis factor-α. Exp. Hematol. 21, 461.
42. 42. Wiltschke C., Krainer M., Wagner A., Linkesch W. & Zielinski C. C. (1995) Influence of in vivo administration of GM-CSF and G-CSF on monocyte cytotoxicity. Exp. Hematol. 23, 402.
43. 43. Gerhartz H. H., Engelhard M., Meusers P., Brittinger G., Wilmanns W., Schlimok G., Mueller P., Huhn D., Musch R., Siegert W., Gerhartz D., Hartlapp J. H., Thiel E., Huber C., Peschl C., Spann W., Emmerich B., Schadek C., Westerhausen M., Pees H. W., Radtke H., Engert A., Terhardt E., Schick H., Binder T., Fuchs R., Hasford J., Brandmaier R., Stern A. C., Jones T. C., Ehrlich H. J., Stein H., Parwaresch M., Tiemann M. & Lennert K. (1993) Randomized, double-blind, placebo-controlled, Phase III study of recombinant human granulocyte-macrophage colony-stimulating factor as adjunct to induction treatment of high-grade malignant non-Hodgkin's lymphomas. Blood 82, 2329.
44. 44. Stevenson H. C., Foon K. A. & Sugarbaker P. H. (1986) Ex vivo activated monocytes and adoptive immunotherapy trials in colon cancer patients. Prog. Clin. Biol. Res. 211, 75.
45. 45. McBride W. H., Economou J. S., Nayersina R., Comora S. & Essner R. (1990) Influences of interleukins 2 and 4 on tumor necrosis factor production by murine mononuclear phagocytes. Cancer Res. 50, 2949.